TABLE 2.
SYSTEMIC ANTIVIRAL THERAPIES WITH OR WITHOUT CORTICOSTEROID IN 24 PATIENTS WITH ACUTE RETINAL NECROSIS TREATED WITH COMBINATION SYSTEMIC AND INTRAVITREAL ANTIVIRAL THERAPY VS SYSTEMIC ANTIVIRAL THERAPY ALONE
| TREATMENT GROUP AND MEDICATION(S) ADMINISTERED | NUMBER OF PATIENTS (%) |
|---|---|
| Combination systemic and intravitreal (foscarnet) | |
| Total | 12 (100) |
| Intravenous acyclovir | 2 |
| Valacyclovir* | 7 |
| Oral acyclovir | 1 |
| Famciclovir | 1 |
| Valganciclovir | 1 |
| Prednisone | 8 |
| Systemic antiviral alone | |
| Total | 12 (100) |
| Intravenous acyclovir | 8 |
| Oral acyclovir | 3 |
| Famciclovir | 1 |
| Prednisone | 4 |
*
Five patients received 1 gm 3 times daily (TID), and 3 patients received 2 gm TID, per infectious disease specialist recommendation.